U.S. Department of Health and Human Services
 

 From NIDDK's Director

 
 

 NIDDK on Social Media

 
​​​​​​​​​​​​​​
Page Divider
​​
Brief articles and multimedia about recent novel trials and results funded or conducted by NIDDK.
NIDDK News Item

Feb 19, 2015

In an NIH-supported clinical trial comparing three drugs for diabetic macular edma (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at the start of the trial.

NIDDK News Item

Jan 6, 2015

People with type 1 diabetes who intensively control their blood glucose (blood sugar) early in their disease are likely to live longer than those who do not, according to research funded by the National Institutes of Health.

NIDDK News Item

Jan 5, 2015

Dr. Siminerio begins a two-year term as chair of the National Diabetes Education Program in January 2015.

NIDDK News Item

Dec 17, 2014

Young children who have long-term high blood sugar levels are more likely to have slower brain growth, according to researchers at centers including the National Institutes of Health.

NIDDK News Item

Nov 17, 2014

Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health (NIH). One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.

View all News Releases